Human medicines European public assessment report (EPAR): Tigecycline Accord, tigecycline, Date of authorisation: 17/04/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Tigecycline Accord, tigecycline, Date of authorisation: 17/04/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 10/06/2022, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 10/06/2022, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg), Date of authorisation: 14/04/2011, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg), Date of authorisation: 14/04/2011, Revision: 27, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness